High rhinovirus burden in lower airways of children with cystic fibrosis

Chest

Volumn 143, Issue 3, 2013, Pages 782-790

  Kieninger, Elisabeth ^a,b   Singer, Florian ^a,b   Tapparel, Caroline ^c   Alves, Marco P ^a   Latzin, Philipp ^a,b   Tan, Hui Leng ^d   Bossley, Cara ^d   Casaulta, Carmen ^a   Bush, Andrew ^d   Davies, Jane C ^d   Kaiser, Laurent ^c   Regamey, Nicolas ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 8;

ADOLESCENT; ARTICLE; ASTHMA; BRONCHIECTASIS; CHILD; CHRONIC RESPIRATORY TRACT DISEASE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IN VIVO STUDY; INFANT; INFLAMMATION; LOWER RESPIRATORY TRACT; LUNG FUNCTION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINOVIRUS; SCHOOL CHILD; VIRUS LOAD;

EID: 84874976278     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-0954     Document Type: Article

References (46)

1. Wang EE, Prober CG, Manson B, Corey M, Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med. 1984; 311 (26): 1653-1658.
2. Smyth AR, Smyth RL, Tong CY, Hart CA, Heaf DP. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child. 1995; 73 (2): 117-120.
3. Hiatt PW, Grace SC, Kozinetz CA, et al. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics. 1999; 103 (3): 619-626.
4. van Ewijk BE, van der Zalm MM, Wolfs TF, et al. Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study. Pediatrics. 2008; 122 (6): 1171-1176.
5. Wat D, Gelder C, Hibbitts S, et al. The role of respiratory viruses in cystic fibrosis. J Cyst Fibros. 2008; 7 (4): 320-328.
6. Collinson J, Nicholson KG, Cancio E, et al. Effects of upper respiratory tract infections in patients with cystic fibrosis. Thorax. 1996; 51 (11): 1115-1122.
7. Burns JL, Emerson J, Kuypers J, et al. Respiratory viruses in children with cystic fibrosis: viral detection and clinical findings. Influenza Other Respi Viruses. 2012; 6 (3): 218-223
8. Papadopoulos NG, Bates PJ, Bardin PG, et al. Rhinoviruses infect the lower airways. J Infect Dis. 2000; 181 (6): 1875- 1884.
9. Zheng S, De BP, Choudhary S, et al. Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis. Immunity. 2003; 18 (5): 619-630.
10. Xu W, Zheng S, Goggans TM, et al. Cystic fibrosis and normal human airway epithelial cell response to influenza a viral infection. J Interferon Cytokine Res. 2006; 26 (9): 609-627.
11. Sutanto EN, Kicic A, Foo CJ, et al Australian Respiratory Early Surveillance Team for Cystic Fibrosis. Innate inflammatory responses of pediatric cystic fibrosis airway epithelial cells: effects of nonviral and viral stimulation. Am J Respir Cell Mol Biol. 2011; 44 (6): 761-767.
12. Vareille M, Kieninger E, Alves MP, et al. Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells. Thorax. 2012; 67 (6): 517-525.
13. Chattoraj SS, Ganesan S, Faris A, Comstock A, Lee WM, Sajjan US. Pseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis but not in normal bronchial epithelial cells. Infect Immun. 2011; 79 (10): 4131-4145.
14. Chattoraj SS, Ganesan S, Jones AM, et al. Rhinovirus infection liberates planktonic bacteria from biofilm and increases chemokine responses in cystic fibrosis airway epithelial cells. Thorax. 2011; 66 (4): 333-339.
15. Kieninger E, Vareille M, Kopf BS, et al. Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis. Eur Respir J. 2012; 39 (2): 297-304.
16. Farrell PM, Rosenstein BJ, White TB, et al Cystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008; 153 (2): S4 - S14.
17. Global strategy for asthma management and prevention. Revised 2002. Global Initiative for Asthma website. http://www.ginasthma.org. Accessed October 10, 2011.
18. Hansell DM. Bronchiectasis. Radiol Clin North Am. 1998; 36 (1): 107-128.
19. Ferkol T, Rosenfeld M, Milla CE. Cystic fibrosis pulmonary exacerbations. J Pediatr. 2006; 148 (2): 259-264.
20. Regamey N, Tsartsali L, Hilliard TN, et al. Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis. Thorax. 2012; 67 (2): 164-170.
21. Hilliard TN, Regamey N, Shute JK, et al. Airway remodelling in children with cystic fibrosis. Thorax. 2007; 62 (12): 1074-1080.
22. Regamey N, Ochs M, Hilliard TN, et al. Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2008; 177 (8): 837-843.
23. Tan HL, Regamey N, Brown S, Bush A, Lloyd CM, Davies JC. The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med. 2011; 184 (2): 252-258.
24. de Blic J, Midulla F, Barbato A, et al European Respiratory Society. Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. Eur Respir J. 2000; 15 (1): 217-231.
25. Tapparel C, Cordey S, Van Belle S, et al. New molecular detection tools adapted to emerging rhinoviruses and enteroviruses. J Clin Microbiol. 2009; 47 (6): 1742-1749.
26. Schibler M, Yerly S, Vieille G, et al. Critical analysis of rhinovirus RNA load quantification by real-time reverse transcription- PCR. J Clin Microbiol. 2012; 50 (9): 2868-2872.
27. Vareille M, Kieninger E, Edwards MR, Regamey N. The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev. 2011; 24 (1): 210-229.
28. Ramsey BW, Gore EJ, Smith AL, Cooney MK, Redding GJ, Foy H. The effect of respiratory viral infections on patients with cystic fibrosis. Am J Dis Child. 1989; 143 (6): 662-668.
29. Gerna G, Piralla A, Rovida F, et al. Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients. J Med Virol. 2009; 81 (8): 1498-1507.
30. Message SD, Laza-Stanca V, Mallia P, et al. Rhinovirusinduced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A. 2008; 105 (36): 13562-13567.
31. Denlinger LC, Sorkness RL, Lee WM, et al. Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation. Am J Respir Crit Care Med. 2011; 184 (9): 1007-1014.
32. Mallia P, Message SD, Gielen V, et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med. 2011; 183 (6): 734-742.
33. Holtzman M, Patel D, Kim HJ, You Y, Zhang Y. Hypersusceptibility to respiratory viruses as a shared mechanism for asthma, chronic obstructive pulmonary disease, and cystic fibrosis. Am J Respir Cell Mol Biol. 2011; 44 (6): 739-742.
34. Cohen TS, Prince A. Cystic fibrosis: a mucosal immunodefi- ciency syndrome. Nat Med. 2012; 18 (4): 509-519.
35. Parker D, Cohen TS, Alhede M, Harfenist BS, Martin FJ, Prince A. Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells. Am J Respir Cell Mol Biol. 2012; 46 (1): 6-13.
36. Xatzipsalti M, Psarros F, Konstantinou G, et al. Modulation of the epithelial inflammatory response to rhinovirus in an atopic environment. Clin Exp Allergy. 2008; 38 (3): 466-472.
37. Durrani SR, Montville DJ, Pratt AS, et al. Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J Allergy Clin Immunol. 2012; 130 (2): 489-495.
38. Hector A, Kormann MS, Mack I, et al. The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease. PLoS ONE. 2011; 6 (9): e24399.
39. Ratjen F. Changes in strategies for optimal antibacterial therapy in cystic fibrosis. Int J Antimicrob Agents. 2001; 17 (2): 93-96.
40. Malfroot A, Adam G, Ciofu O, et al European Cystic Fibrosis Society (ECFS) Vaccination Group. Immunisation in the current management of cystic fibrosis patients. J Cyst Fibros. 2005; 4 (2): 77-87.
41. Giebels K, Marcotte JE, Podoba J, et al. Prophylaxis against respiratory syncytial virus in young children with cystic fibrosis. Pediatr Pulmonol. 2008; 43 (2): 169-174.
42. Papi A, Contoli M. Rhinovirus vaccination: the case against. Eur Respir J. 2011; 37 (1): 5-7.
43. Rohde GG. Rhinovirus vaccination: the case in favour. Eur Respir J. 2011; 37 (1): 3-4.
44. Simon HU, Seelbach H, Ehmann R, Schmitz M. Clinical and immunological effects of low-dose IFN-alpha treatment in patients with corticosteroid- resistant asthma. Allergy. 2003; 58 (12): 1250-1255.
45. Coates M, Charron C, Ito K. Effects of RV1088, a novel narrow spectrum kinase inhibitor, on pro-inflammatory cytokine production in epithelial cells isolated from patients with cystic fibrosis. J Cyst Fibros. 2011; 10 (6): S16.
46. Gielen V, Johnston SL, Edwards MR. Azithromycin induces anti-viral responses in bronchial epithelial cells. Eur Respir J. 2010; 36 (3): 646-654.